Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.
- Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University School of Medicine
- Professor, Vascular & Interventional, Radiology, Boston University School of Medicine
- Harvard Medical School, MD
- Brown University, BS
- Published on 12/24/2018
Cheng TW, Farber A, Eslami MH, Kalish JA, Jones DW, Rybin D, Siracuse JJ. Removal of infected arteriovenous grafts is morbid and many patients do not receive a new access within 1 year. J Vasc Surg. 2018 Dec 24. PMID: 30591289.
- Published on 12/21/2018
Roberts L, Farber A, Jones DW, Woo K, Eslami MH, Simons J, Malas M, Tan TW, Rybin D, Siracuse JJ. Tapered arteriovenous grafts do not provide significant advantage over nontapered grafts in upper extremity dialysis access. J Vasc Surg. 2018 Dec 21. PMID: 30583896.
- Published on 12/4/2018
Siracuse JJ, Farber A, Cheng TW, Raulli SJ, Jones DW, Kalish JA, Smeds MR, Rybin D, Schermerhorn ML. Common femoral artery antegrade and retrograde approaches have similar access site complications. J Vasc Surg. 2018 Dec 04. PMID: 30527937.
- Published on 11/27/2018
Siracuse JJ, Farber A, James T, Cheng TW, Zuo Y, Kalish JA, Jones DW, Kalesan B. Readmissions after Firearm Injury Requiring Vascular Repair. Ann Vasc Surg. 2018 Nov 27. PMID: 30500659.
- Published on 11/24/2018
Eslami MH, Saadeddin ZM, Rybin DV, Avgerinos ED, Eslami PW, Siracuse JJ, Farber A. Trends and Outcomes of Pediatric Vascular Injuries in the United States: An Analysis of the National Trauma Data Bank. Ann Vasc Surg. 2018 Nov 24. PMID: 30476614.
- Published on 11/1/2018
Arinze N, Farber A, Sachs T, Patts G, Kalish J, Kuhnen A, Kasotakis G, Siracuse JJ. The effect of statin use and intensity on stroke and myocardial infarction after carotid endarterectomy. J Vasc Surg. 2018 Nov; 68(5):1398-1405. PMID: 29685507.
- Published on 10/24/2018
Eslami MH, Saadeddin Z, Rybin DV, Doros G, Siracuse JJ, Farber A. Association of frailty index with perioperative mortality and in-hospital morbidity after elective lower extremity bypass. J Vasc Surg. 2018 Oct 24. PMID: 30527215.
- Published on 10/6/2018
Tan TW, Siracuse JJ, Brooke BS, Baril DT, Woo K, Rybin D, Doros G, Farber A. Comparison of one-stage and two-stage upper arm brachiobasilic arteriovenous fistula in the Vascular Quality Initiative. J Vasc Surg. 2018 Oct 06. PMID: 30301685.
- Published on 9/11/2018
Raulli SJ, Cheng TW, Farber A, Eslami MH, Kalish JA, Jones DW, Rybin DV, Nuhn M, Gautam A, Siracuse JJ. Intraoperative Heparin Use during Upper Extremity Arteriovenous Access Creation Does Not Affect Outcomes. Ann Vasc Surg. 2018 Sep 11. PMID: 30217706.
- Published on 7/12/2018
Farber A. Chronic Limb-Threatening Ischemia. N Engl J Med. 2018 07 12; 379(2):171-180. PMID: 29996085.
View 215 more publications: View full profile at BUMC